Recent

% | $
Quotes you view appear here for quick access.

Alnylam Pharmaceuticals, Inc. Message Board

rdiggerg 4 posts  |  Last Activity: Apr 12, 2015 8:56 PM Member since: Dec 11, 2005
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Mesoblast-Celgene news

    by rdiggerg Apr 12, 2015 8:03 PM
    rdiggerg rdiggerg Apr 12, 2015 8:56 PM Flag

    Mesoblast is already up 20% in Austrian trading. This is a giant step forward with a well capitalized company (CELG) to bring Prochymal to market sometime in our lifetime. Potential huge royalties to OSIR which was not a real possibility only because Mesoblast did not have the necessary capital . Now, with CELG as a partner, investor, and collaborator...look out. Suddenly, this is the real deal.

  • Mesoblast-Celgene collaboration deal for advancement of GVHD. This should be big for ORIS.......................

  • Reply to

    Mesoblast/Osiris

    by rdiggerg Feb 15, 2015 7:18 PM
    rdiggerg rdiggerg Feb 15, 2015 9:37 PM Flag

    ......correction, 80-95% of children die without the drug. That is after every other option to try to save them, A virtual death sentence without MSC-100-IV.

  • rdiggerg by rdiggerg Feb 15, 2015 7:18 PM Flag

    More amazing survival data released for GVHD in children on Mesoblast website. 5-20% of these children die without the Mesoblast/Orisis drug. Survival of the sickest of the sick up to 80% with the drug. How much longer are the regulators around the globe going to drag their feet on approval and reimbursement. Same amazing data reported and replicated for over ten years now. What a disgrace.

ALNY
119.01+0.29(+0.24%)Apr 24 4:00 PMEDT